Skip to content
Cypher Genomics logo — Unlocking the potential of human genome data through automat...

Cypher Genomics

Unlocking the potential of human genome data through automated interpretation for clinical labs and pharmaceutical research.

Founded 2011 United States San Diego, United States 2 employees Non Equity Assistance Analytics, Biotechnology +1

General Information

Company Name Cypher Genomics
Founded Year 2011
Location United States San Diego, United States
Employees 2
Industries Analytics, Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Cypher Genomics. To contact Cypher Genomics, visit cyphergenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cypher Genomics compare?

A PDF of Cypher Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cypher Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cypher Genomics

Cypher Genomics is a biotech startup that focuses on genome informatics, providing automated software solutions for the interpretation of human genomes. Their platform is designed to cater to clinical labs, pharmaceutical companies, and population genomics initiatives, unlocking the potential of human genome data for various applications. Founded in 2011 by Ashley Van Zeeland and based in La Jolla, California, Cypher Genomics has carved out a niche in the industry. Their innovative approach allows clinical laboratories to customize the sensitivity and specificity of Cypher Genomics' profiles, facilitating the development of molecular tests for diagnosis and prognosis. Moreover, pharmaceutical companies can leverage the platform to identify biomarkers using whole genome sequence data in early-stage drug development studies. This versatility makes Cypher Genomics a valuable asset in both clinical and research settings. The recent non-equity assistance investment at 01 November 2016 by EvoNexus signifies continued interest and support in Cypher Genomics' endeavors. Furthermore, the acquisition of Cypher Genomics by Human Longevity underscores the company's potential and the attractiveness of its technology in the market. In summary, Cypher Genomics is at the forefront of genome informatics, offering automated interpretation solutions that have garnered attention from investors and industry players alike. With its focus on clinical applications and pharmaceutical research, the company is well-positioned to make significant contributions to the evolving landscape of genomics and biotechnology.

Business keywords: Genome Informatics, Genomic Interpretation, Clinical Laboratories, Molecular Tests, Pharmaceutical Research, Biomarker Discovery, Whole Genome Sequencing, Diagnostic Tools, Prognostic Tools, Population Genomics, Automated Software Solutions, Human Longevity, Drug Development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
EvoNexus
01 Nov 2016
Non Equity Assistance Undisclosed 1
EvoNexus
01 May 2012

Cypher Genomics Alternatives & Competitors

View All Alternatives
Cypher Genomics vs
Congenica
Congenica United Kingdom

Driving Precision Medicine

Acquired
23 employees
Biotechnology, Health Care
Cypher Genomics vs
GENOME INSIGHT INC.
GENOME INSIGHT INC. United States

Cancer whole genome platform company

Series B
54 employees
Analytics, Biotechnology
Cypher Genomics vs

Pioneering the integration of human disease into pharmaceutical discovery, advancing biomedical rese...

Series C
Biotechnology, Health Care

FAQ About Cypher Genomics

Unlocking the potential of human genome data through automated interpretation for clinical labs and pharmaceutical research.
Cypher Genomics was founded in 2011.
Cypher Genomics is headquartered in San Diego, United States.
Cypher Genomics operates in Analytics, Biotechnology and Health Care. Its work centres on Genome Informatics, Genomic Interpretation, Clinical Laboratories and Molecular Tests.
Cypher Genomics has approximately 2 employees.
Cypher Genomics has completed 2 funding rounds. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Cypher Genomics include Congenica, GENOME INSIGHT INC., Ardais Corporation, Tute Genomics, IntegraGen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cypher Genomics and Congenica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cypher Genomics, https://bouncewatch.com/company/cypher-genomics, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout